Sysmex raised its earnings forecast for the fiscal year ending March 2027, citing strong performance by its hematology instruments in the Americas. The stock has risen for five consecutive sessions in response.
Sysmex raised its earnings forecast for the fiscal year ending March 2027, as demand for hematology instruments in the Americas remained strong.
According to Mynavi's related stock information, Sysmex's share price was ¥1,981.5 as of 10:45, up 19.98% from the previous day.
Although the specific figures for the announcement were not provided in the article, strong performance in the Americas market was cited as the reason for the upward revision.
Following the move, attention is also focusing on the performance of related stocks.